GT Biopharma
Westlake Village
About GT Biopharma
GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of immunology therapeutic products based on our proprietary Trispecific Killer Engagers (TriKE™) target-directed Natural Killer (NK) cell engager platform. The TriKE™ NK protein biologic platform is designed to harness and amplify the body’s native immune system for hope for patients with cancer and infectious diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $75.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Feb 2025)
- Ticker: epa:GTBP
- Website: gtbiopharma.com
- Phone: 310-860-5184
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/gt-biopharma-28637 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.